𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Post-transfusion purpura: An enigma of alloimmunization

✍ Scribed by Peter Lau; Carol M. Sholtis; Richard H. Aster


Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
365 KB
Volume
9
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A patient with post‐transfusion purpura is reported. This female patient, sensitized by previous blood transfusion, developed symptomatic thrombocytopenia seven days after a second blood transfusion. A platelet antibody, which had anti‐P1 ^A1^ specificity, was identified by ^51^Cr‐release assay and by indirect immunofluorescence. Hemorrhage stopped abruptly after plasma exchange therapy. Thrombocytopenia did not recur when the patient was further challenged with P1^A1^‐positive blood and plasma. Anti‐P1^A1^ antibody, detectable by immunofluorescence but not by complement‐dependent platelet cytoxicity, persisted in high titer for at least one year after recovery. The heterogeneity and pathogenesis of this clinical syndrome are discussed.


📜 SIMILAR VOLUMES


Post-transfusion purpura associated with
✍ Rudolph M. Keimowitz; Janice Collins; Kent Davis; Richard H. Aster 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 649 KB

Post-transfusion purpura (PTP) with severe thrombocytopenia occurred eight days after transfusion in a 28-year-old woman and responded to treatment with prednisone and plasma exchange. In contrast to nearly all previously studied cases of PTP, the patient's platelets were PlA1-positive and anti-Pl\*

Successful prevention of post-transfusio
✍ Anderson, Barry; Shad, Aziza T.; Gootenberg, Joseph E.; Sandler, S. Gerald 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 18 KB 👁 2 views

Alloimmunization to the D blood group antigen following the transfusion of D-positive red blood cells to a D-negative recipient may be prevented in most persons by a prompt and adequate dose of Rho (D) immune globulin (RhIG). Until recently, the only RhIG approved by the US Food and Drug Administrat